The Nobel laureate’s discoveries led to a treatment for Parkinson’s disease.

Researchers initially set out to investigate the relationship between copper homeostasis and the rare Menkes disease, but they also found links to Parkinson’s.

New details of the molecular process by which our cells consume themselves point to therapeutic potential.

The elimination of these glia in the mouse brain ameliorated the development of Parkinsonian neuropathologies induced by the pesticide toxin paraquat.  

The company’s recent effort to find new treatments for Alzheimer’s ended in disappointment.

With a clinical trial underway to restore vision optogenetically, researchers also see promise in using the technique to treat deafness, pain, and other conditions.

Rodent studies presented at the Society for Neuroscience meeting this week tie pathologies in the gastrointestinal tract or microbiome composition with Parkinson’s and Alzheimer’s diseases.

Neurons derived from human induced pluripotent stem cells fill in for lost dopamine neurons in a primate model of the disease.

In mice, injected fragments of a naturally occurring protein boost memory in young and old animals and improve cognition and mobility in a model of neurodegenerative disease.